BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-06-12
• Last 15 days FTD volume: £0.02 M
• Last 3 months FTD volume: £5.14 M
• Last 12 months FTD volume: £7.48 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	£10.01 M	£0.12 B	🇺🇸 USA
GSK plc GSK	£54.45 M	£0.22 B	🇬🇧 UK
Sarepta Therapeutics SRPT	£11.87 M	£23.12 M	🇺🇸 USA
Repligen RGEN	£18.77 M	£34.03 M	🇺🇸 USA
Novavax NVAX	£15.47 M	£57.27 M	🇺🇸 USA
Celldex Therapeutics CLDX	£0.86 M	£11.01 M	🇺🇸 USA
NanoViricides NNVC	£1.09 M	£4.65 M	🇺🇸 USA
Cel-Sci CVM	£0.72 M	£5.87 M	🇺🇸 USA
Emergent BioSolutions EBS	£0.15 M	£3.45 M	🇺🇸 USA